# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-074563
Filing Date
2023-09-07
Accepted
2023-09-07 07:25:21
Documents
24
Period of Report
2023-09-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea184830-6k_canfitebio.htm | 6-K | 9546
2 | CORPORATE PRESENTATION | ea184830ex99-1_canfitebio.htm | EX-99.1 | 29953
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 182413
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 409779
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 125603
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 162352
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 105420
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 158846
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 148805
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 218543
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 155815
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 160665
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 101344
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 147692
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 188626
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 191909
17 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 195157
18 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 158638
19 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 132095
20 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 174413
21 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 163564
22 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 163820
23 | GRAPHIC | ex99-1_021.jpg | GRAPHIC | 193586
24 | GRAPHIC | ex99-1_022.jpg | GRAPHIC | 175555
| Complete submission text file | 0001213900-23-074563.txt |  | 5296599

Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 231240964
SIC: 2834 Pharmaceutical Preparations